XOMAP Q3 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+888.3% YoY

Gross Profit

$9M98.4% margin

Operating Income

$3M32.6% margin

Net Income

$3M35.9% margin

EPS (Diluted)

$0.28

QoQ Revenue Growth

+820.5%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$86M

Total Liabilities

$60M

Stockholders' Equity

$26M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$896,000	+888.3%
Gross Profit	$9M	$259,000	+3263.7%
Operating Income	$3M	-$5M	+154.5%
Net Income	$3M	-$5M	+169.4%